CHINA SXT PHARMACEUTICALS IN (SXTC) Stock Income Statement
NASDAQ:SXTC - Nasdaq - VGG2161P1577 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.82M | 1.93M | 1.97M | 2.60M | 4.78M | |||
| Cost Of Goods | 1.42M | 1.37M | 1.55M | 1.35M | 1.94M | |||
| Gross Profit | 400.40K | 554.00K | 430.00K | 1.25M | 2.84M | |||
| Operating Expenses | -5.80M | 2.65M | 5.68M | 6.44M | 5.03M | |||
| Selling, General, and Administrative Expenses | -5.80M | 2.65M | 5.68M | 6.44M | 5.04M | |||
| Operating Income | 6.20M | -2.09M | -5.26M | -5.19M | -2.20M | |||
| Interest Income/Expense | -390.30K | -544.30K | -480.00K | -40.00K | -1.62M | |||
| Other Income/Expense | -10.20K | -39.00K | 150.00K | -180.00K | 870.00K | |||
| Non Recurring Items | N/A | -422.90K | -350.00K | 0.00 | 0.00 | |||
| Income Before Taxes | 5.79M | -3.10M | -5.93M | -5.41M | -2.94M | |||
| Income Tax | N/A | 0.00 | 0.00 | 330.00K | -190.00K | |||
| Net Income | 5.79M | -3.10M | -5.93M | -5.74M | -2.75M | |||
| EBITDA | 6.36M | -1.89M | -5.01M | -4.87M | -1.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 40.81 | -28.58 | -21.96 | -143.50 | -91.66 | |||
| Statistics | ||||||||
| Gross Profit Margin | 22.02% | 28.73% | 21.83% | 48.08% | 59.41% | |||
| Profit Margin | 318.69% | -160.67% | -301.02% | -220.77% | -57.53% | |||
| Operating Profit Margin | 340.71% | -108.49% | -267.01% | -199.62% | -46.03% | |||
All data in USD